Vivos Therapeutics, Inc.VVOSNASDAQ

Revenue (LTM)

$15M

+8.9% YoY

Net Income (LTM)

$-11M

+18.0% YoY

Free Cash Flow

$-13M

Revenue CAGR (5Y)

+3.6%

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	13	17↑29.2%	16↓5.1%	14↓13.9%	15↑8.9%
Gross Profit	10	13↑21.0%	10↓20.5%	8↓17.4%	9↑9.0%
Operating Income	-9	-19↓123.6%	-25↓28.6%	-17↑30.9%	-11↑35.4%
Net Income	-12	-20↓68.3%	-24↓17.5%	-14↑43.0%	-11↑18.0%
EBITDA	-11	-20↓73.8%	-24↓24.7%	-17↑31.6%	-11↑36.7%
EPS Diluted	-24.70	-23.89↑3.3%	-25.90↓8.4%	-11.14↑57.0%	-2.22↑80.1%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	18	24↑32.0%	4↓85.4%	2↓53.3%	6↑281.0%
Total Current Assets	20	27↑34.0%	5↓80.1%	2↓54.6%	7↑203.7%
Total Assets	25	34↑33.0%	14↓59.3%	11↓21.8%	15↑42.4%
Total Current Liabilities	8	8↓4.0%	7↓9.3%	7↑7.0%	5↓31.7%
Total Liabilities	8	8↓3.1%	9↑9.4%	10↑15.7%	7↓29.0%
Total Equity	17	26↑51.0%	5↓81.2%	0↓91.4%	8↑1835.3%
Total Debt	1	2↑26.5%	2↑47.9%	2↓17.3%	2↓24.2%
Net Debt	-17	-22↓32.4%	-1↑95.1%	0↑131.8%	-5↓1448.9%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-6	-16↓177.0%	-20↓24.5%	-12↑39.0%	-13↓6.2%
Capital Expenditure	-0	-2↓1892.5%	-1↑61.4%	-1↑13.1%	-1↑29.3%
Free Cash Flow	-6	-18↓212.6%	-21↓13.1%	-13↑37.8%	-13↓4.0%
Stock-Based Comp	2	3↑22.4%	2↓9.9%	1↓61.4%	1↓17.5%
Net Change in Cash	18	6↓67.2%	-21↓452.2%	-2↑90.9%	5↑346.1%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance